Isoprotrace® is a PSMA-11 (Gozetotide) radiolabelling kit indicated for prostate cancer imaging. This ready-to-use, multi-dose kit allows healthcare professionals to efficiently prepare Gallium (68Ga) Gozetotide for I.V. injection. For specific usage instructions, please consult the product’s information.
As trusted distributor for Isotopia in the Netherlands, we are committed to ensuring that Isoprotrace® reaches medical facilities across the country. In addition, our partnership extends to distributing Lutetium 177 n.c.a., enhancing access to advanced imaging and therapeutic tools for cancer care. Prostate cancer remains a major health challenge worldwide, and precise imaging is vital for early detection, accurate diagnosis, and effective treatment planning.
November is International Prostate Cancer Month, a time dedicated to raising awareness about prostate cancer, its diagnosis, and treatment. The launch of Isoprotrace® aligns with this important month, reinforcing our commitment to enhancing prostate cancer care. By providing access to advanced imaging tools like Isoprotrace®, we aim to support early detection and more precise treatment planning, helping healthcare providers deliver better patient outcomes.
For more details on Isoprotrace® and its applications in prostate cancer imaging, please reach out to us. Our team is available to answer your questions, provide product information, and arrange demonstrations to showcase the benefits. Click on this link to get in contact with us.
